You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Exercise Disclosure
Robinson James A. Jr. · SEC Form 4 · Filed Aug 28, 2026
Exercise
Calculated transaction value
$0
Robinson James A. Jr. Director
URGN
UroGen Pharma Ltd
URGN
Transaction date
Aug 26, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 2 days later
URGN daily price context
Close on/before transaction
$45.94
Aug 26, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Ordinary Shares
- Quantity / price
- 2,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-029175
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN | Exercise | Aug 26, 2026 | Not reported |
| Urogen Pharma Ltd. URGN Current | Exercise | Aug 26, 2026 | $0 |